Health

  • November 05, 2026

    Ropes & Gray-Led Pharma Biz Offers $541M For Swedish Rival

    U.S. biopharma company ANI said Thursday it has offered to acquire Swedish pharmaceutical company Egetis for up to approximately 5.3 billion Swedish kronor ($541 million) to gain access to a newly approved drug.

  • November 04, 2026

    Pharmacy Worker Says Dosage Machine Cut Off Fingertip

    A pharmacy worker suffered a "traumatic" finger amputation when a machine that dispenses liquid medication caught her index finger and ripped part of it off, according to a lawsuit in Pennsylvania state court that accuses medical device manufacturer Precision Products Group Inc. of defective design.

  • November 04, 2026

    Anthem Fights Rework Of Neurosurgery Group Antitrust Case

    A pair of Anthem units are pushing back against a Long Island, New York, neurosurgery practice's bid to file an amended complaint accusing the insurer of driving down reimbursement rates, telling a New York federal court the changes fail to fix the problems that resulted in a previous dismissal.

  • November 04, 2026

    Colo. Co. Accused Of Misusing $400K Loan For HHS Deal

    A Colorado public benefit corporation breached a loan agreement by failing to use the $400,000 loan for its intended purpose and instead diverting the loan to settle a nearly $600,000 civil penalty with a federal government agency, according to a lender's lawsuit in Colorado state court.

  • November 04, 2026

    Anti-Pot Group Eyes New Repeal Pushes After Mass. Loss

    After Election Day, anti-cannabis activists are pledging to bring repeal efforts to other states despite a decisive defeat in Massachusetts, while pro-cannabis industry and consumer-focused groups say they hope to work with a Democrat-controlled Congress to secure federal reform.

  • November 04, 2026

    2nd Circ. Told To Not Expand Antitrust Patent Fraud Standing

    A pharmaceutical industry trade group has backed Bristol-Myers Squibb and its Celgene subsidiary in the Second Circuit, warning that health plans asking the appeals court to reinstate a proposed class action against the companies are seeking to expand who can bring antitrust cases alleging fraudulently obtained patents.

  • November 04, 2026

    AGs Say Taro's $200M MDL Deal Doesn't Bar Their Claims

    Dozens of state attorneys general urged a Connecticut federal judge Tuesday not to let Taro Pharmaceuticals block a swath of their price-fixing claims with a $200 million settlement it struck with plaintiffs in separate multidistrict litigation, arguing the claims and plaintiffs are too separate to bind one another.

  • November 04, 2026

    Walgreens Seeks Sanctions In Investors' Pharma Growth Suit

    Walgreens has asked an Illinois federal judge to sanction investors and their attorneys in a securities fraud class action, arguing they continued to falsely attribute statements about the company's plans to open hundreds of clinics to a former executive even after a recording showed his statement was taken out of context.

  • November 04, 2026

    4 Argument Sessions For Benefits Attys To Watch In Nov.

    JPMorgan Chase & Co. will defend its win in a 401(k) forfeiture suit at the Ninth Circuit, Aetna will ask the Second Circuit to push a multiemployer health plan's suit into arbitration, and the Tenth Circuit hears from pharmacy benefit managers who want an opioid nuisance battle moved to federal court. Here, Law360 looks at four arguments that benefits attorneys may want to keep an eye on in November.

  • November 04, 2026

    Mass. Justices Doubt Nantucket's Rationale For PFML Denial

    Massachusetts' highest court appeared to push back Wednesday on assertions by Nantucket that it cannot implement the state's Paid Family and Medical Leave Act for employees of the island enclave, despite a town meeting vote, because some of its unions have not agreed to bargain over the cost.

  • November 04, 2026

    Highmark Health Network Hit With Suit Over AI Recording Use

    Allegheny Health Network and its parent Highmark Health failed to get informed consent from patients for use of an artificial intelligence-based clinical documentation tool in exam rooms, according to a patient's proposed class action complaint in Pennsylvania state court.

  • November 04, 2026

    MVP: Holland & Knight's Jennifer Weaver

    Dubbed the "Queen of the False Claims Act" by an opposing counsel, Jennifer Weaver of Holland & Knight LLP convinced the government to drop its investigation into California's Cedars-Sinai Medical Center and successfully defended a Puerto Rican cardiologist against FCA and kickback claims, earning her a spot as one of the 2026 Law360 Healthcare MVPs.

  • November 04, 2026

    EU Committees OK Tighter Controls On Drug Inputs

    Two European Parliament committees voted Wednesday to advance draft measures they said would strengthen controls on chemicals used to manufacture illegal drugs like heroin and cocaine.

  • November 04, 2026

    Abortion Measures Split State Voters In Midterm Election

    Reproductive and gender-affirming care rights were on ballots in several states Tuesday night, as the Idaho electorate rejected a measure that would have overturned its anti-abortion laws, while voters in Nevada and other states passed measures expanding abortion protections.

  • November 04, 2026

    CVS To Split In 2, Unraveling Decade-Old Megamerger

    CVS Health said Wednesday that it plans to split into two independent, publicly traded companies, separating its Aetna- and Caremark-led healthcare businesses from its 9,000 retail pharmacy locations, reversing its nearly decade-old combination of the businesses.

  • November 03, 2026

    Va., Mo. Voters Deliver Wins For Abortion Rights

    Supporters of abortion access won key victories Tuesday in Virginia and Missouri as voters across the country took up healthcare measures that will shape state laws on reproductive and gender-affirming care, according to partial, unofficial returns.

  • November 03, 2026

    Mass., Idaho Voters Defeat Anti-Cannabis Ballot Measures

    Voters in Massachusetts and Idaho on Tuesday rejected efforts to repeal or restrict marijuana legalization, dealing a blow to anti-cannabis activists and lawmakers who sought to turn Election Day into a referendum on voter-led efforts to reform drug laws.

  • November 03, 2026

    New Calif. Governor Promises Litigation-Heavy Agenda

    Former state attorney general and U.S. Health and Human Services Secretary Xavier Becerra's projected win in the California governor's race Tuesday night tees up fresh legal battles with the Trump administration and puts immigration, insurance and artificial intelligence policy at the top of lawyers' watch lists.

  • November 03, 2026

    Feds Dropping Charges Against Harvard Researcher

    The government is dropping charges against a Harvard researcher and Russian national who was found with preserved clawed frog embryo samples at Boston's Logan International Airport last year, according to a filing Tuesday evening.

  • November 03, 2026

    Birth Control Clip Maker Must Face Injury Case Trial

    Medical device importer and distributor CooperSurgical Inc. failed to secure quick wins on several claims in a bellwether product liability case alleging injuries from Filshie Clip birth control devices, with a Connecticut state judge finding that federal law does not preempt six women's failure-to-warn allegations.

  • November 03, 2026

    Ga. Court Affirms Toss Of $7.5M Verdict In Patient Death Suit

    A Georgia appeals court on Tuesday affirmed a trial judge's decision to wipe out a jury's $7.5 million verdict against healthcare providers accused of negligently discharging an emergency room patient who was later hit and killed by a car, saying the plaintiffs failed to prove the providers' alleged negligence caused the death.

  • November 03, 2026

    Youth File Fresh Appeal In Colo. Hospital Gender Care Suit

    Transgender youth patients of Children's Hospital Colorado have brought yet another challenge to a judge's discharge of their contempt citation against the hospital for not resuming providing them medical gender-affirming care, this time asking the Colorado Court of Appeals to weigh in on whether the hospital complied with an injunction.

  • November 03, 2026

    3M Inks $7.35B Deal To Settle Most PFAS Foam Claims

    3M Co. announced Tuesday that it will pay up to $7.35 billion over nine years to resolve nearly all personal injury claims related to PFAS "forever chemicals" in firefighting foam.

  • November 03, 2026

    PBM Says Fla. Collusion Suit Belongs In Federal Court

    A pharmacy benefit manager accused by Florida's attorney general of colluding with a competitor to fix prescription drug reimbursement rates for pharmacies removed the state's suit to federal court, citing its work for federal and military employees.

  • November 03, 2026

    Mallinckrodt Loses $9.5M Award, Wins Delay In Airgas Drug

    A Delaware federal judge on Tuesday threw out Mallinckrodt Pharmaceuticals' $9.5 million jury award it won in an infringement case and instead blocked a competitor's inhaled nitric oxide treatment patent until after a pair of Mallinckrodt's patents expire.

Expert Analysis

  • Series

    Open-Water Swimming Makes Me A Better Lawyer

    Author Photo

    Swimming long distances in open waters is not necessarily an escape from my intellectual property practice, but a complementary discipline that similarly rewards sustained attention, intellectual curiosity, resilience and the ability to pursue a distant objective without losing command of the immediate task, says Christina MacDougall at Morgan Lewis.

  • What To Expect From Calif.'s Incoming Health AI Laws

    Author Photo

    California's new statewide ground rules for artificial intelligence in clinical care, set to take effect on Jan. 1, reveal the Legislature's choice to regulate healthcare AI primarily though institutions, rather than direct product regulation, and providers should shape their compliance plans accordingly, say attorneys at Reed Smith.

  • Opinion

    The Invisible AI Danger That May Undermine Legal Profession

    Author Photo

    A public database tracking cases involving hallucinations generated by artificial intelligence recently surpassed 2,200 entries, but the bigger risk underlying attorneys’ use of such tools is that they will slowly surrender their judgment to AI and lose analytical skills, says Massachusetts District Court Associate Justice Brian Palmucci.

  • How Cos. Using AI Agents Can Avoid Protected Data Incidents

    Author Photo

    For businesses whose deployed artificial intelligence agents could enter other companies' systems and steal protected data, deployers can take several steps before an incident to test the configured agent, such as limiting it to approved systems and destinations and requiring human escalation when tasks stall, says Steven Carlson at von Briesen & Roper.

  • DOL Association Health Plan Rule Could Cut Employer Costs

    Author Photo

    The U.S. Department of Labor's proposed rule would redefine who may act as an employer for purposes of sponsoring a group health plan under the Employee Retirement Income Security Act, potentially extending cost relief to many more businesses, says W. James Hamilton at Bose McKinney.

  • FDA Classification Setback Bodes Well For Wound Care Cos.

    Author Photo

    A Georgia federal court's recent decision in MiMedx v. U.S. Food and Drug Administration constrains the FDA's analytical framework for classifying certain wound care products as biological products, carrying important ramifications for manufacturers seeking to avoid heightened regulatory requirements, say attorneys at Hyman Phelps.

  • Lessons For Cannabis Dispensaries From Web Tracking Suits

    Author Photo

    The trajectory of health-tracking litigation in Florida and elsewhere suggests that patient privacy claims will not disappear quickly, so dispensaries should audit their sites, tighten consent and align their disclosures with their actual practices, say attorneys at Buchanan Ingersoll.

  • Defending Hospital Antisteering Clauses From DOJ Scrutiny

    Author Photo

    The Trump administration has recently made clear that pursuing antitrust challenges to antisteering provisions in hospital-insurer contracts is a priority — but a review of similar cases against hospital systems and important precedent from the U.S. Supreme Court illuminates some potential defenses in such cases, says Derek Moore at Rule Garza.

  • How AI Could Help Judges Spot Their Own Biases

    Author Photo

    In close cases where there’s room for discretion, artificial intelligence could challenge judges’ implicit biases by running counterfactual tests at scale — but any judicial use of such tools would need guardrails, say Arnold Peter at Peter Law and Nancy Rapoport at University of Nevada.

  • What Expanded CMS Authority Means For Health Compliance

    Author Photo

    A recent delegation gives the Centers for Medicare & Medicaid Services independent authority to impose permissive exclusions, creating a more active federal enforcement system with heightened risks for healthcare organizations, says Jose Vela at Clark Hill.

  • New Manhattan DA Task Force Puts Antitrust In Its Crosshairs

    Author Photo

    The Manhattan District Attorney's Office's new corporate crime and antitrust task force is adding local criminal enforcement to a field long led by federal authorities, meaning companies need to account for potential parallel federal and state antitrust investigations when responding to misconduct, say attorneys at Ropes & Gray.

  • 3 Strategies To Reduce AI Sycophancy In Legal Work

    Author Photo

    The tendency of generative artificial intelligence models to tell users what they want to hear can reinforce attorneys’ confirmation bias when testing the strength of arguments, and it can’t simply be prompted away — but a few practices can help mitigate it, says Michael Ott at Ice Miller.

  • DOJ Directive Gives Contractors A Fraud Risk Road Map

    Author Photo

    For government contractors, the 10 factors described in the U.S. Department of Justice's recent corporate fraud enforcement directive function as a de facto scoring rubric for internal audits that mirrors what prosecutors will prioritize, say attorneys at Spencer Fane.

  • 2nd Circ. EFAA Ruling Shifts Employer Litigation Strategy

    Author Photo

    In Diaz-Roa v. Hermes Law, the Second Circuit recently held that, under the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act, employers can't carve out nonharassment claims and send them to arbitration, which has implications for discovery, litigation costs and resolution strategy in EFAA-covered disputes, say attorneys at Krevolin Horst.

  • 3rd Circ. Ruling Opens Door For Fraud-On-The-Market Rethink

    Author Photo

    The Third Circuit's recent decision in Ocugen, holding that a stable stock price after publication of restated financials does not prove immateriality, could be a vehicle for the U.S. Supreme Court to overturn the doctrine undergirding certification of securities class actions, says Jonathan Richman at Brown Rudnick.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here